Cargando…

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients

Bones are the most common metastatic site of relapse in breast cancer patients and the prediction of bone metastases (BM) risk might prompt developing preventive and therapeutic strategies. The aim of the study was to correlate imumohistochemical (IHC) expression of selected proteins in primary brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winczura, Piotr, Sosińska-Mielcarek, Katarzyna, Duchnowska, Renata, Badzio, Andrzej, Lakomy, Joanna, Majewska, Hanna, Pęksa, Rafał, Pieczyńska, Beata, Radecka, Barbara, Dębska-Szmich, Sylwia, Adamowicz, Krzysztof, Biernat, Wojciech, Jassem, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550640/ https://www.ncbi.nlm.nih.gov/pubmed/26062800 http://dx.doi.org/10.1007/s12253-015-9957-0

Ejemplares similares

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
por: Duchnowska, Renata, et al.
Publicado: (2016)

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
por: Duchnowska, Renata, et al.
Publicado: (2017)

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012)

Molecular Profiles of Brain Metastases: A Focus on Heterogeneity
por: Ali, Shan, et al.
Publicado: (2021)

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
por: Duchnowska, Renata, et al.
Publicado: (2022)

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer
por: Hryciuk, Beata, et al.
Publicado: (2020)

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
por: Żok, Jolanta, et al.
Publicado: (2021)

Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells
por: Pęksa, Rafał, et al.
Publicado: (2022)

The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases
por: Gril, Brunilde, et al.
Publicado: (2018)

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
por: Pęksa, Rafał, et al.
Publicado: (2021)

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
por: Krakowska, Magdalena, et al.
Publicado: (2018)

Castleman’s disease mimicking lymph node metastases in a young woman with laryngeal cancer
por: Serkies, Krystyna, et al.
Publicado: (2016)

Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review
por: Wrona, Ewa, et al.
Publicado: (2021)

PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
por: Sznurkowski, Jacek J., et al.
Publicado: (2017)

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
por: Nicoś, Marcin, et al.
Publicado: (2022)

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number
por: Szutowicz-Zielinska, Ewa, et al.
Publicado: (2016)

Synchronous primary ovarian and endometrial cancers: a series of cases and a review of literature
por: Dębska-Szmich, Sylwia, et al.
Publicado: (2014)

Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2009)

Malignant acanthosis nigricans associated with prostate cancer: a case report
por: Kubicka-Wołkowska, Joanna, et al.
Publicado: (2014)

The role of preoperative systemic treatment in patients with breast cancer
por: Dębska-Szmich, Sylwia, et al.
Publicado: (2016)

Urothelial carcinoma of the prostate with raised β-hCG levels: a case report
por: Sołek, Julia, et al.
Publicado: (2022)

Secondary cancer in a survivor of Hodgkin’s lymphoma: A case report and review of the literature
por: LISIK-HABIB, MAJA, et al.
Publicado: (2015)

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
por: Wu, Natalie C., et al.
Publicado: (2018)

Childhood longitudinal melanonychia: case series from Poland
por: Sobjanek, Michał, et al.
Publicado: (2019)

Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial Cancer()
por: Supernat, Anna, et al.
Publicado: (2014)

Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review
por: Duchnowska, Renata, et al.
Publicado: (2021)

Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus
por: Zapała, Łukasz, et al.
Publicado: (2022)

Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy
por: Niwinska, Anna, et al.
Publicado: (2022)

Prostate Cancer and Its Mimics—A Pictorial Review
por: Żurowska, Anna, et al.
Publicado: (2023)

Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma
por: Pęksa, Rafał, et al.
Publicado: (2023)

Dietary habits of lung cancer patients from the Lower Silesia region of Poland
por: Zabłocka-Słowińska, Katarzyna, et al.
Publicado: (2015)

ALK alterations in salivary gland carcinomas
por: Majewska, Hanna, et al.
Publicado: (2020)

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study
por: Kunc, Michał, et al.
Publicado: (2020)

Expression of HTRA Genes and Its Association with Microsatellite Instability and Survival of Patients with Colorectal Cancer
por: Zurawa-Janicka, Dorota, et al.
Publicado: (2020)

Association of Dietary Inflammatory Index with Serum IL-6, IL-10, and CRP Concentration during Pregnancy
por: Pieczyńska, Joanna, et al.
Publicado: (2020)

Radiotherapy in thoracic malignancies: the preface
por: Jassem, Jacek, et al.
Publicado: (2021)

Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma
por: Kunc, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_61aonds2b6pdfo5k9suak9rako